Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance.

García-Marco JA, Jiménez JL, Recasens V, Zarzoso MF, González-Barca E, De Marcos NS, Ramírez MJ, Parraga FJP, Yañez L, De La Serna Torroba J, Malo MDG, Ariznavarreta GD, Persona EP, Guinaldo MAR, De Paz Arias R, Llanos EB, Jarque I, Valle MDCF, Tatay AC, De Oteyza JP, Martin EMD, Fernández IP, Martinez RM, Costa MAA, Champ D, Suarez JG, Díaz MG, Ferrer S, Carbonell F, García-Vela JA; GELLC Study Group.

Haematologica. 2019 Nov;104(11):2249-2257. doi: 10.3324/haematol.2018.204891. Epub 2019 Mar 19.

2.

Response to imatinib mesylate in patients with hypereosinophilic syndrome.

Arefi M, García JL, Briz MM, de Arriba F, Rodríguez JN, Martín-Núñez G, Martínez J, López J, Suárez JG, Moreno MJ, Merino MA, Gutiérrez NC, Hernández-Rivas JM.

Int J Hematol. 2012 Sep;96(3):320-6. doi: 10.1007/s12185-012-1141-7. Epub 2012 Jul 18.

PMID:
22806436
3.

Unbalanced intake of fats and minerals associated with hypertension risk in young cyclists.

Sánchez-Benito JL, Sánchez-Soriano E, Suárez JG.

Nutr Hosp. 2007 Sep-Oct;22(5):552-9.

PMID:
17970538
4.

Scale-up of recombinant Opc protein production in Escherichia coli for a meningococcal vaccine.

Pérez RE, Lasa AM, Rodríguez RS, Menéndez EC, Suárez JG, Balaguer HD.

J Biotechnol. 2006 Dec 15;127(1):109-14. Epub 2006 Jun 21.

PMID:
16893582

Supplemental Content

Loading ...
Support Center